Feed aggregator

Man blows up underground bunker while making hash oil, burning self and two others, sheriff says

Cannabist - Wed, 08/30/2017 - 00:04
A Larimer County man has been arrested on suspicion of child abuse after building an underground fallout bunker and then allegedly cooking hash oil in the room, blowing it up injuring himself and a juvenile.

Oklahoma Has Spent Over $2 Million to Drug Test Welfare Applicants, Less than 3% Tested Positive

The Joint Blog - Tue, 08/29/2017 - 23:45
Oklahoma has squandered millions of dollars drug testing applicants for welfare over the past five years, with just a minimal percentage testing positive.

Since Oklahoma implemented a policy for drug testing applicants of the Temporary Assistance to Needy Families funds in 2012, the state has spent over $2.2 million administering such tests. Out of 19,878 individuals drug tested under the new law, just 2.8% tested positive for drug use.

As part of the law, those applying for welfare are mandated to complete a drug screening. Those deemed likely to be drug users must then undergo a drug test; those testing positive for an illegal substance are banned from receiving funding for at least a year, unless they seek treatment in which case the ban is reduced to six months.

In 2014 the 11th U.S. Circuit Court of Appeals ruled unanimously that a similar program in Florida is unconstitutional. The court concluded that there’s no evidence to explain why it’s necessary to force individuals seeking welfare to submit to unreasonable search in order to receive aid, and suggested that the policy plays on stereotypes.

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post Oklahoma Has Spent Over $2 Million to Drug Test Welfare Applicants, Less than 3% Tested Positive appeared first on TheJointBlog.

President Trump Rescinds Order Limiting Police Militarization

The Joint Blog - Tue, 08/29/2017 - 21:05
President Trump has officially repealed an order that limits police militarization.

On Monday the Trump Administration rescinded Executive Order 13688, which limited the Pentagon’s ability to transfer some kinds of military equipment to state and local police departments. According to the American Civil Liberties Union, the move “leaves law enforcement’s federally provided drones, explosives, and Mine Resistant Ambush Protected Vehicles without oversight.”

“Military equipment should only be transferred to police if departments can prove appropriate use, training, and oversight, and that the equipment will only be used in specific and necessary circumstances, such as active shooter scenarios,” says Major Neill Franklin (Ret.), executive director of the Law Enforcement Action Partnership (LEAP). “At tremendous risk to public safety, the 1033 Program doesn’t require these vital measures.

Major Franklin goes on to state that; “We must stop reinforcing the mentality that police are warriors and civilians are the enemy – it endangers everyone.”

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post President Trump Rescinds Order Limiting Police Militarization appeared first on TheJointBlog.

Three Marijuana Strains Inspired by Game of Thrones

The Joint Blog - Tue, 08/29/2017 - 19:10

By Evan Hundhausen, Herb.co

With the seventh season of Game of Thrones officially over, and with just one season remaining, we thought now was the time to take a look at some marijuana strains inspired by the hit show. Whitewalker OG

Whitewalker OG is bred by Gold Coast Extracts. It won first place at the High Times 2013 Amsterdam Cannabis Cup. Jake Browne of “The Cannabist” said this after sampling the strain, “(it) almost entirely shut down the speech center of my brain and made movement feel labored.” Woh, man! Maybe that’s exactly how those white walkers in the show really feel anyhow. You can also find another strain called White Walker Kush bred by DNA genetics.

 

Khaleesi Kush

Khaleesi Kush is a Game of Thrones strain invented by HighRise Seeds, but the seeds seem to have sold out fast and are not available at the time of this writing. It’s an indica and has genetics of Lavatera, Pakistani Kush and Bubblegum.

 

Blackwater

Blackwater is a potent Indica, which received 3rd place at the High Times 2014 Los Angeles Cannabis Cup. The flowers are purple and known to be sticky with a grape aroma. It’s bred by The Cali Connection. Just to remind you, “The Battle of the Blackwater” was when Tyrion Lannister (Yes, the short guy.) lead his army into battle and sent out the stuff called “wildfire” blowing up all those ships!

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post Three Marijuana Strains Inspired by Game of Thrones appeared first on TheJointBlog.

Update: Nevada liquor group loses appeal over marijuana transport rules

Cannabist - Tue, 08/29/2017 - 19:07
Nevada's marijuana regulators have rejected an appeal by a group of alcohol distributors who wanted to block the state from licensing pot businesses to transport marijuana from growers to retail stores.

FDA Seeking Public Comments On CBD

NORML Blog - Tue, 08/29/2017 - 16:58

On Regulations.Gov, right now, the Federal Food and Drug Administration (FDA) is soliciting public comments with regard to the therapeutic utility and abuse liability of various controlled substances, including cannabidiol (CBD).

The agency will consider these comments prior to preparing a formal response to the World Health Organization, which is considering placing the substances within their international drug scheduling code.

Now, to be frank, it’s a little silly that the FDA is seeking public comment on a topic that would normally be judged based on the merits of evidence-based science and data. But prohibition itself would be considered silly if not for the detrimental effects of a criminal record and lifelong penalties and stigma associated with it.

That being said, cannabidiol is defined by the US Drug Enforcement Administration as a Schedule I controlled substance, despite:

  • Its therapeutic properties and lack of abuse potential, despite the safety trials which have determined the substance to be non-toxic and well-tolerated in human subjects
  • Seventeen states explicitly recognizing by state-law that CBD as a therapeutic agent
  • The head of the US National Institute on Drug Abuse publically acknowledging that CBD is “a safe drug with no addictive effects” 

So a request for public comment should never go unfulfilled. So we made it incredibly easy for you to do so.

CLICK HERE TO SUBMIT FORMAL COMMENTS TO THE FDA NOW

Consumers still prefer bud to edibles or extracts

The Leaf Online - Tue, 08/29/2017 - 14:55

Herbal bud remains far more popular among cannabis consumers than are edibles or extracts; at least, according to an analysis of retail sales data in Washington state. Researchers from Carnegie Mellon University in Pittsburgh PA and from the RAND Corporation in Santa Monica CA reviewed sales data from over 36 million separate retail cannabis transactions […]

The post Consumers still prefer bud to edibles or extracts appeared first on The Leaf Online.

Tennessee Has Organized A Medical Marijuana Committee

Weed News - Tue, 08/29/2017 - 14:45
Tennessee is one of several states in America that has passed a CBD-specific cannabis law. CBD-specific cannabis laws are largely non-beneficial to most medical cannabis patients, and...

[[ This is a content summary only. Visit my website for full links, other content, and more! ]]

What Is A Cannabis ‘Tarantula Joint’?

Weed News - Tue, 08/29/2017 - 14:03
I have smoked a lot of joints over the course of the last 25 years. It is, and always will be, one of my favorite ways to consume cannabis. I don’t consume as many of them as I used to since I...

[[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Seattle Hempfest 2017: 3 Days of Peace For 26 Years

Weed News - Tue, 08/29/2017 - 13:42
This year MSM seemed not to pay attention to Seattle Hempfest as if it’s not prevalent or inconsequential, but I assure you, this is not the case. While thousands peacefully smoke their...

[[ This is a content summary only. Visit my website for full links, other content, and more! ]]

CN NS: Making Their Voices Heard

MAP - Hemp - Tue, 08/29/2017 - 07:00
The Journal-Pioneer, 29 Aug 2017 - Supporters of marijuana advocate protest outside Amherst courthouse Support for a Cumberland County man charged with marijuana and firearm offences showed up early Monday for his first court appearance since being arrested almost a week ago.

CN NS: Making Their Voices Heard

MAP - Cannabis - Tue, 08/29/2017 - 07:00
The Journal-Pioneer, 29 Aug 2017 - Supporters of marijuana advocate protest outside Amherst courthouse Support for a Cumberland County man charged with marijuana and firearm offences showed up early Monday for his first court appearance since being arrested almost a week ago.

CN MB: Town Hall To Bring Clarity On Legal Pot

MAP - Cannabis - Tue, 08/29/2017 - 07:00
Metro, 29 Aug 2017 - A town hall in St. James Tuesday night will try to clear the air for any Winnipeggers with questions about cannabis legalization in advance of a legislation review this fall. Hosted by Charleswood-St. James-Assiniboia-Headingley MP Doug Eyolfson, the event will feature an in-depth review of Bill C-45-which would amend the Controlled Drugs and Substances Act, Criminal Code and other acts-expert testimony from witnesses at the federal health committee.

CN QU: Legal Pot, But At What Price?

MAP - Cannabis - Tue, 08/29/2017 - 07:00
The Record, 29 Aug 2017 - Provinces agree marijuana cost, quality and access must be competitive with black market: Blair MONTREAL - There is an overwhelming national consensus that legal marijuana must be priced, taxed and made available competitively with the black market, the man tasked with leading the drug's legalization in Canada said Monday.

CN NS: Tasty Budds Dispensaries Reopen

MAP - Cannabis - Tue, 08/29/2017 - 07:00
Metro, 29 Aug 2017 - 'Alleged illegal activity' only at one location All five Tasty Budds medical marijuana dispensaries in Nova Scotia have reopened following raids last week, and allegations of illegal activity that the chain's owner says were confined to just one location.

FDA Grants Breakthrough Therapy Designation to MDMA (Ecstasy) for PTSD

The Joint Blog - Mon, 08/28/2017 - 22:06
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to MDMA (the main compound found in ecstasy) for the treatment of posttraumatic stress disorder (PTSD).

The non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to MDMA for the treatment of posttraumatic stress disorder (PTSD). MAPS and the FDA have also reached agreement under the Special Protocol Assessment Process (SPA) for the design of two upcoming Phase 3 trials (MAPP1 and MAPP2) of MDMA-assisted psychotherapy for patients with severe PTSD.

MDMA-assisted psychotherapy is a novel treatment package that combines psychotherapeutic techniques with three administrations of MDMA as a pharmacological adjunct.

By granting Breakthrough Therapy Designation, the FDA has agreed that this treatment may have a meaningful advantage and greater compliance over available medications for PTSD.

The first Phase 3 trial (MAPP1), “A Randomized, Double-Blind, Placebo-Controlled, Multi-Site Phase 3 Study of the Efficacy and Safety of Manualized MDMA-Assisted Psychotherapy for the Treatment of Severe Posttraumatic Stress Disorder,” will begin enrolling subjects in Spring 2018, after the completion of an open-label lead-in training study at Phase 3 sites starting this fall.

“Reaching agreement with FDA on the design of our Phase 3 program and having the ability to work closely with the agency has been a major priority for our team,” said Amy Emerson, Executive Director of the MAPS Public Benefit Corporation (MPBC). “Our Phase 2 data was extremely promising with a large effect size, and we are ready to move forward quickly. With breakthrough designation, we can now move even more efficiently through the development process in collaboration with the FDA to complete Phase 3.”

“For the first time ever, psychedelic-assisted psychotherapy will be evaluated in Phase 3 trials for possible prescription use, with MDMA-assisted psychotherapy for PTSD leading the way,” said Rick Doblin, Founder and Executive Director of MAPS. “Now that we have agreement with FDA, we are ready to start negotiations with the European Medicines Agency.”

The Phase 3 trials will assess the efficacy and safety of MDMA-assisted psychotherapy in 200-300 participants with PTSD, aged 18 and older, at sites in the U.S., Canada, and Israel. Participants will be randomized to receive three day-long sessions of either MDMA or placebo in conjunction with psychotherapy over a 12-week treatment period, along with 12 associated 90-minute non-drug preparatory and integration sessions. The primary endpoint will be the Clinician Administered PTSD Scale (CAPS-5), as assessed by a blinded pool of independent raters.

In MAPS’ completed Phase 2 trials with 107 participants, 61% no longer qualified for PTSD after three sessions of MDMA-assisted psychotherapy two months following treatment. At the 12-month follow-up, 68% no longer had PTSD. All Phase 2 participants had chronic, treatment-resistant PTSD, and had suffered from PTSD for an average of 17.8 years.

MDMA transiently increases heart rate, blood pressure, and body temperature in a dose-dependent manner that is generally not problematic for physically healthy individuals. Serious Adverse Events involving administration of MDMA in MAPS studies have been uncommon and non-life threatening. Phase 2 trial results are currently being prepared for publication.

About Breakthrough Therapies

The FDA grants Breakthrough Therapy Designation to treatments that (1) are intended alone or in combination with one or more other drugs to treat a serious or life-threatening disease or condition; and (2) preliminary clinical evidence indicates may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. Since 2012, the FDA has implemented this program to expedite the development and review of any treatment designated as a breakthrough therapy. For more information, see the FDA’s Fact Sheet.

About Special Protocol Assessments

The Special Protocol Assessment (SPA) process is an agreement resulting from official evaluation and written guidance from FDA on the protocol design, clinical endpoints, planned conduct, and statistical analyses for the Phase 3 trial to ensure they are acceptable to support regulatory approval. Final marketing approval depends on the efficacy results, adverse event profile, and an evaluation of the ratio of risks and treatment benefits demonstrated in the Phase 3 clinical program. The SPA agreement may only be changed through a written agreement between the sponsor and the FDA, or if the FDA becomes aware of a substantial scientific issue essential to product efficacy or safety. For more information, see the FDA’s Guidance for Industry.

About MDMA-Assisted Psychotherapy

MDMA-assisted psychotherapy is a novel treatment package that combines psychotherapy with the administration of MDMA (approved generic name: midomafetamine) to achieve significant and lasting reductions in PTSD symptoms. MDMA is administered in three single-dose psychotherapy sessions administered in a clinic setting spaced three to five weeks apart, along with preparatory and integration sessions. Phase 2 clinical trials have shown that MDMA can reduce fear and defensiveness, enhance communication and introspection, and increase empathy and compassion. These combined neurological effects can enhance the therapeutic process for people suffering from PTSD.

About PTSD

PTSD is a serious, long-lasting, and life-threatening condition when not adequately treated, highlighting the need for expedited approval of new therapies. PTSD sufferers may relive their traumatic experiences through nightmares and flashbacks, have difficulty sleeping, and feel detached from daily life. Approximately 7% of the U.S. population, and 11-17% of U.S. military veterans, will have PTSD sometime in their life. As of June 2016, more than 868,000 veterans were receiving disability compensation for PTSD, with an estimated taxpayer cost of $17 billion per year. PTSD is a stress-related condition associated with reduced cognitive and psychosocial functioning, fractured relationships, inability to maintain employment, substance abuse, and increased risk of depression and suicide. In the general population, 27% of suicides are associated with PTSD.

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post FDA Grants Breakthrough Therapy Designation to MDMA (Ecstasy) for PTSD appeared first on TheJointBlog.

Congressman O’Rourke Introduces Amendment To End Arbitrary License Suspensions

NORML Blog - Mon, 08/28/2017 - 20:39

Congressman Beto O’Rourke (D-TX) with Representatives Amash (R-MI), Jeffries (D-NY), Nadler (D-NY) have introduced an amendment to the appropriations bill that the House is expected to take up next month. The amendment would eliminate the funding for enforcement of Section 159 of title 23, which reduces highway funding for states if they did not automatically suspend drivers licenses of anyone convicted of a drug offense.

This amendment is similar to the Better Drive Act, which Congressman O’Rourke introduced in April. The Better Drive Act removes the federal mandate that demands states to suspend the driver’s license of individuals with a marijuana possession conviction. Currently, any drug conviction, regardless of whether or not the motor vehicle was involved, results in an automatic suspension of the individual’s driving privileges for a period of six months.

Enacted over 25 years ago as a part of the so-called “War on Drugs,” this mandate imposed on states does not improve highway safety or help people address substance abuse. Rather, it had the opposite effect, as this mandate ends up costing minor offenders their ability to get to work and to school, and other undue economic hardships.

By adding an amendment to eliminate the financial penalty against states who do not follow the federal mandate, O’Rourke and his co-sponsors are pushing to ease the burdens against those whom are convicted for simple marijuana possession.

Click here to send a message to you member of the House to support the amendment and companion legislation, The Better Drive Act.

Texas resident? Congressman Beto O’Rourke has been working closely with Texas NORML to address federal reform. Click here to find out more about Texas NORML and follow them on Facebook and Twitter.

Conference of State Legislatures asks to de-schedule cannabis

The Leaf Online - Mon, 08/28/2017 - 19:58

State lawmakers from around the nation called for a new federal law to de-schedule cannabis, allow financial institutions to provide banking services to state-legal marijuana businesses and give states control of their cannabis policies without federal interference. A recent federal review also suggested leaving cannabis policy up to the states. National reform resolution passed The […]

The post Conference of State Legislatures asks to de-schedule cannabis appeared first on The Leaf Online.

Netflix Develops Line of Marijuana Strains Inspired by their Shows

The Joint Blog - Mon, 08/28/2017 - 18:30
In an interesting move, popular streaming service Netflix has developed a line of marijuana strains meant to be consumed with some of their most popular shows.

According to a press release each of the new strains were “cultivated with the specific shows in mind, designed to complement each title based on their tone.” For example, “sillier shows may be more indica dominant, while dramedies will be more sativa dominant to help the more powerful scenes resonate.”

Three of the strains – Omega Strain, Eve’s Bush, and Rutherford B. Haze – were created to compliment one of Netflix’s newest shows Disjointed, about a California-based dispensary owner. Other strains include:

  • The Camp Firefood strain inspired by Wet Hot American Summer: Ten Years Later, described as a “very chill indica”
  • Banana Stand Kush inspired by Arrested Development
  • Vodkush inspired by Chelsea
  • Prickly Muffin inspired by Bojack Horseman
  • Peyotea 73 inspired by Grace and Frankie
  • Sassafrass OG inspired by Lady Dynamite
  • Poussey Riot inspired by Orange in the new Black
  • Baka Bile inspired by Santa Clarita Diet; and
  • Moon 13 inspired by Mystery Science Theater 300 Returns

 

According to Netflix, they aren’t making a profit from these strains, which were developed for promotional purposes.

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post Netflix Develops Line of Marijuana Strains Inspired by their Shows appeared first on TheJointBlog.

Review: Netflix rolls out 'Disjointed,' starring Kathy Bates, created by TV guru Chuck Lorre

Cannabist - Mon, 08/28/2017 - 17:21
It might take a medicinal brownie or two to really enjoy the new Netflix comedy “Disjointed.”
Syndicate content